An evaluation of empagliflozin and it's applicability to hypertension as a therapeutic option.

Introduction: Sodium-glucose cotransporter 2 (SGLT2) inhibitors such as Empagliflozin are novel antihyperglycemic drugs approved for the treatment of type 2 diabetes (T2D). In addition to its gluco...